My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

29.36 -0.88 (-2.90%)

Streaming Delayed Price Updated: 10:57 AM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

29 30 Next >

This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025? ↗

January 22, 2025

Via The Motley Fool

Why Viking Therapeutics Stock Popped, but Novo Nordisk and Hims & Hers Health Dropped Today ↗

January 17, 2025

Via The Motley Fool

Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today ↗

January 16, 2025

Via Benzinga

We Asked Retail How Viking Therapeutics Can Restore Investor Confidence: Majority Say Pursue Buyout Talks ↗

January 15, 2025

Oppenheimer earlier this month listed Viking as one of five biotech companies that could be prime candidates for an "aspirational" takeover.

Via Stocktwits

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Dropped on Tuesday ↗

January 14, 2025

Via The Motley Fool

Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts. ↗

January 09, 2025

Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.

Via Investor's Business Daily

Topics Artificial Intelligence Government

Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years ↗

December 30, 2024

Via Benzinga

3 Mid-Cap Stocks That Could Take Off in 2025 ↗

January 09, 2025

Via The Motley Fool

Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst ↗

January 06, 2025

JPMorgan highlights valuation resets for Viking and Structure Therapeutics, citing opportunities in T2D/obesity and competitive clinical data insights.

Via Benzinga

1 Under-the-Radar Stock to Buy Before It Soars by 156%, According to Select Wall Street Analysts ↗

January 06, 2025

This is a high-risk, high-reward stock.

Via The Motley Fool

Why Viking Therapeutics Stock Plummeted by 24% in December ↗

January 04, 2025

Via The Motley Fool

Should You Buy the Dip on This High-Flying Stock? ↗

January 03, 2025

Via The Motley Fool

StoryTrading's Secrets To January Gains - Don’t Miss These Picks ↗

January 02, 2025

As we usher in the new year, market dynamics continue to be shaped by a blend of tax-deferral selling, the January effect, and macro uncertainties.

Via Talk Markets

Topics Stocks / Equities

Looking Into Viking Therapeutics's Recent Short Interest ↗

December 20, 2024

Via Benzinga

$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today ↗

December 16, 2024

Via Benzinga

3 Stocks That Could Be Monster Winners in 2025 ↗

December 29, 2024

Via The Motley Fool

Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck? ↗

December 21, 2024

Via The Motley Fool

My Top 10 Stocks to Buy for 2025 ↗

December 21, 2024

Via The Motley Fool

Why Viking Therapeutics Tumbled by More Than 10% This Week ↗

December 20, 2024

Via The Motley Fool

Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up ↗

December 20, 2024

Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for.

Via The Motley Fool

Stock Market Tumbles, Treasury Yields Soar On Fed Rate Outlook: Weekly Review ↗

December 20, 2024

Micron, Vertex, Novo Nordisk and Nike were notable losers on news.

Via Investor's Business Daily

Topics Economy

Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump. ↗

December 20, 2024

Eli Lilly and Viking Therapeutics jumped on Novo's setback.

Via Investor's Business Daily

From Powell To Profits: Strategic Stock Picks Amid Market Uncertainty ↗

December 19, 2024

Yesterday's market movement aligned perfectly with expectations, as the FOMC meeting drove significant volatility.

Via Talk Markets

Topics Stocks / Equities

What's Going On With Viking Therapeutics Stock On Wednesday? ↗

December 18, 2024

Merck partners with Hansoh Pharma for GLP-1 drug development, while analysts highlight Viking's obesity assets as key for future growth.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

December 18, 2024

Via Benzinga

Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche ↗

December 18, 2024

Under the deal's terms, Hansoh Pharma receives $112 million up front and a potential $1.9 billion in milestone payments.

Via Investor's Business Daily

9 Health Care Stocks With Whale Alerts In Today's Session ↗

December 16, 2024

Via Benzinga

Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? ↗

December 16, 2024

The weight-loss drugs space continues to heat up. Here's the latest news from the segment.

Via Investor's Business Daily

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 ↗

December 16, 2024

Via The Motley Fool

2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street ↗

December 15, 2024

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.